Avanos Medical (AVNS) EBIT Margin (2016 - 2024)
Historic EBIT Margin for Avanos Medical (AVNS) over the last 12 years, with Q3 2024 value amounting to 7.04%.
- Avanos Medical's EBIT Margin rose 63400.0% to 7.04% in Q3 2024 from the same period last year, while for Sep 2024 it was 4.92%, marking a year-over-year increase of 35100.0%. This contributed to the annual value of 0.62% for FY2023, which is 45700.0% down from last year.
- As of Q3 2024, Avanos Medical's EBIT Margin stood at 7.04%, which was up 63400.0% from 3.67% recorded in Q2 2024.
- Over the past 5 years, Avanos Medical's EBIT Margin peaked at 9.14% during Q4 2022, and registered a low of 62.57% during Q4 2021.
- In the last 5 years, Avanos Medical's EBIT Margin had a median value of 0.7% in 2023 and averaged 2.94%.
- Its EBIT Margin has fluctuated over the past 5 years, first plummeted by -370600bps in 2021, then soared by 717100bps in 2022.
- Quarter analysis of 5 years shows Avanos Medical's EBIT Margin stood at 25.51% in 2020, then crashed by -145bps to 62.57% in 2021, then soared by 115bps to 9.14% in 2022, then decreased by -29bps to 6.46% in 2023, then increased by 9bps to 7.04% in 2024.
- Its EBIT Margin stands at 7.04% for Q3 2024, versus 3.67% for Q2 2024 and 2.41% for Q1 2024.